摘要
The solution-phase synthesis of a muramyl dipeptide（MDP） analogue of N~α-[4-chlorocinnamoyl-L-alanyl-D-isoglutaminyl]-L-lysine （MDA,2） is reported that possesses the features of easy feasibility,safety and low cost in large scale of synthesis.
The solution-phase synthesis of a muramyl dipeptide（MDP） analogue of N~α-[4-chlorocinnamoyl-L-alanyl-D-isoglutaminyl]-L-lysine （MDA,2） is reported that possesses the features of easy feasibility,safety and low cost in large scale of synthesis.
基金
supported financially by the National Natural Science Foundation of China(No.90713045)
